(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CYPROTEX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CYPROTEX

ST13

US500000079291031

Class

42

Filing

79291031

Registration

6375243

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

06/09/2026

Trademark type

Word

Nice classes

42

Filing date

05/28/2020

Registration date

06/08/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/08/2021

Last transaction

06/09/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

GB

Examiner

OJEYEMI, ASHLEY CHRISTINE

Law office

O10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Cyprotex Discovery Limited

Representatives

William E O'Brien Esq. OBrien Global Law

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Pharmaceutical research and development; contract research organization services (CRO) for pharmaceuticalbiotechnologyagrochemical and chemical industriesmonitoring of clinical trials for drugsbiologics and devices of pharmaceuticalmedicalhealthcarelife sciences companies for quality control purposes and research and development of new products; screening of chemical compounds being testing of chemicals; testing of chemical compounds; absorptiondistributionmetabolismexcretion and toxicology testing of chemical compounds; data analysis of pharmacokinetic properties being testing of pharmaceuticals; computer based predictive methodstesting of pharmaceuticals; provision of scientific information in the field pharmacokinetics; molecular and physiological mathematical modelling being computer modeling services

Publications

History of USPTO decisions and trademark events.

31 publications found

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

06/08/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/06/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

10/25/2021

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/28/2021

FIMP

FINAL DISPOSITION PROCESSED

09/28/2021

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

09/08/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

06/08/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/23/2021

PUBO

PUBLISHED FOR OPPOSITION

03/23/2021

GPNX

NOTIFICATION PROCESSED BY IB

03/22/2021

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

03/03/2021

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

03/03/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/03/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/12/2021

XAEC

EXAMINER'S AMENDMENT ENTERED

02/12/2021

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

02/12/2021

GNEA

EXAMINERS AMENDMENT E-MAILED

02/12/2021

CNEA

EXAMINERS AMENDMENT -WRITTEN

02/12/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/12/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/12/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/12/2021

RFNT

REFUSAL PROCESSED BY IB

10/19/2020

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

09/28/2020

RFRR

REFUSAL PROCESSED BY MPU

09/28/2020

CNRT

NON-FINAL ACTION MAILED

09/08/2020

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

09/07/2020

CNRT

NON-FINAL ACTION WRITTEN

09/06/2020

DOCK

ASSIGNED TO EXAMINER

08/28/2020

MAFR

APPLICATION FILING RECEIPT MAILED

08/11/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/07/2020

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

08/06/2020

Continuous trademark protection

Get notified about every new filing that threatens CYPROTEX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.